<DOC>
	<DOCNO>NCT01173939</DOCNO>
	<brief_summary>The study conduct compare effect standard treatment ( target LDL-C level : &lt; 120 mg/dL ( JASGL 2007 target level ) ) intensive treatment ( target LDL-C level : &lt; 70 mg/dL ) prevention major adverse cardiac event ( MACE ) hypercholesterolemia patient concomitant type 2 diabetes hypertension .</brief_summary>
	<brief_title>Primary Prevention Major Adverse Cardiac Events ( MACE ) With Standard Intensive Statin Treatment Patients With Diabetes : Survival Cardiovascular Event Assessments</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Patients meet follow inclusion criterion include study : 1 . Patients give voluntary write consent participate study 2 . Male female patient 50 year age old ( informed consent ) 3 . Hypercholesterolemia patient ( Untreated patient : LDLC level ≥140 mg/dL ; treat patient : LDLC level ≥120 mg/dL ) 4 . Type 2 diabetes patient ( HbA1c level ≥6.1 % ( JDS criterion ) , without history drug therapy ) 5 . Hypertension patient ( SBP ≥130 mmHg DBP ≥80 mmHg , without history drug therapy ) 6 . Patients two follow risk factor Male 65 year age old Smoker L/H ratio : ≥3.0 •HbA1c level : ≥8.0 % Left ventricular hypertrophy First seconddegree family history MACE Microalbuminuria ( quantitative testing : ≥30 mg/dL ) , proteinuria ( qualitative testing : + high ) eGFR ( &lt; 60 mL/min/1.73 m2 ) Patients meet follow criterion exclude study : 1 . Patients receive rosuvastatin , pitavastatin , atorvastatin therapy within one month prior inform consent 2 . Patients judge familial hypercholesterolemia 3 . Patients serum triglyceride level ≥400 mg/dL 4 . Patients history myocardial infarction 5 . Patients history coronary revascularization ( PCI CABG ) 6 . Patients history treatment unstable angina 7 . Patients history cerebrovascular accident ( exclude asymptomatic lacunar infarction ) 8 . Heart failure patient 9 . Patients history hypersensitivity statins 10 . Patients history druginduced myopathy 11 . Patients poorly control arrhythmia 12 . Patients severe liver kidney disease 13 . Patients serious concurrent disease , malignancy , patient severely limit lifespan 14 . Patients may pregnant 15 . Patients judge investigator ineligible participation study reason</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Hypercholesterolemia concomitant type 2 diabetes hypertension</keyword>
</DOC>